



a new specialty within a proven 
treatment discipline
Epidemiology
Cancer has played an increasingly important role 
in disease and death among the population in 
recent years. In the Netherlands, the country 
where I work for many years now, it is the number 
one cause of death and has thus overtaken 
cardiovascular disease. There are 17 million in-
habitants in our country and more than 110,000 
new cases of cancer occur every year. Almost 
50,000 people die each year from the effects of 
cancer (31% of deaths). More than 40,000 people 
(25%) die from the consequences of cardio-
vascular disease. The chances of survival in 
cancer are increasing and luckily there are now 
560,000 people in the Netherlands with or after 
cancer, the survivors. More about that later. In 
Iceland, 1510 new cancer cases were registered in 
2018, 662 cancer deaths and 4674 survivors 
(five-year survival). Breast cancer, lung cancer 
and prostate cancer were the most commonly reported in Iceland. 
The CONCORD-2 study, published on November 26, 2014 in The 
Lancet, describes the 5-year survival of 25.7 million adult cancer 
patients diagnosed for the ten most common forms of cancer. The 
patient data are from the 1995 to 2009 period and were collected 
using individual patient data from 279 cancer registries in 67 
countries. Even after correcting for differences between countries 
and regions, risk of death from other causes, age, gender, race and 
time course, the researchers found very large differences between 
the various countries in terms of chances of survival for various 
types of cancer. The highest survival rates for breast cancer and 
colon cancer were reported in Israel and Ecuador (68% or higher 
for colon cancer); Qatar, Cyprus and Iceland (70% or more for 
rectal cancer); and in Australia, Brazil, Canada, Cyprus, Israel, 
Japan, USA and a number of European countries, including the 
Netherlands (85% or more for breast cancer). The same study also 
shows that patients with liver or lung cancer have the worst 
prognosis of the ten types of cancer studied. The 5-year survival 
rate was less than 20% in both developed and developing 
countries.
Causes
Why do so many people get cancer? To answer this question it is 
good to go back to the beginning, to cell division. Cancer is un-
regulated growth. This can be caused by mutation, amplification 
and absence of tumor suppression genes. Regarding mutation 
there is a change in the genetic material of the cell, the DNA. 
Concerning amplification, the cell is copied more than twice, 
creating additional growth. In the absence of the tumor supp-
ression gene, the natural inhibition on controlled 
cell growth has disappeared. In all cases, 
unrestrained and abnormal cell growth 
occurs. We use a characterization based on histo-
logy. A carcinoma starts from the epithelial tissue, 
a sarcoma from connective-, muscle-, nerve-, 
cartilage- or bone tissue. A melanoma originates 
from skin pigment cells and a lymphoma from the 
lymph nodes. In addition, there are leukemia and 
multiple myeloma, both based on the bone mar-
row. The staging of cancer is internationally 
classified with a TNM methodology: T for the size 
or extension of the primary tumor, N for the pres-
ence of lymph node metastases and M for the 
interpretation of hematogenic metastases. Why do 
these abnormal cell changes happen? Heredity is 
responsible for 5% of cases. Lifestyle, smoking 
and drinking, together for about 35%. But also 
think about sun rays. Nutrition plays a clear role, 
both the composition and the quantity, therefore obesity is an 
important risk factor. Sometimes a virus damages the genetic ma-
terial e.g. cervical cancer. Ionizing radiation can also cause 
damage to the cell, but in other cases it is often not clear at all. 
Coincidence or bad luck?
Maarten van de Weijden, a well-known Dutch sportsman (Olympic 
gold in the 10 km swimming in open water, Beijing 2008) 
developed lymphatic leukemia in 2001. He healed and then devot-
ed his life to cancer research and fundraising. He says about this: 
“having cancer is stupid, stupid bad luck! Healing is not winning 
and dying not just losing ”. This year he swam a canaltour of 195 
km passing by all the cities in our province of Friesland, a famous 
tour that has traditionally been held as a skating competition. He 
raised more than 6 million euros for cancer research.
Treatment options 
Cancer treatment has changed considerably in recent years. We 
have two treatment goals. These are: curative, focused on healing, 
and palliative, focused on improving, or : maintaining quality of 
life and sometimes on extending it if healing is no longer possible. 
In curative treatment design surgery, radiation, chemotherapy and 
anti-hormonal therapy are the most common. The tumor is 
removed with surgery. Radiation destroys cancer cells. 
Chemotherapy is aimed at disrupting DNA or the protein systems 
and thereby inhibiting the growth or multiplication of cancer cells. 
Anti-hormonal therapy focuses on hormones as a growth acceler-
ating factor. Recently, new treatment methods have been developed 






strengthening the body's immune system. Fortunately, the search 
for new treatment options continues despite the high costs. The 
same options can be used in the palliative treatment design, but 
the trade-off between effectiveness, the contribution to quality of 
life and the unavoidable side effects must always be made. This 
consideration will also change over the course of life, as goals will 
shift.
Side effects
In addition to all the intended effects, the medical treatment 
options also give side effects. These are very diverse in nature, but 
often affect the physical functioning of the patient. Surgery can 
damage parts of the musculoskeletal system. Think of muscles and 
tendons, nerve tissue or blood and lymph vessels. Tissue repair 
does not always lead to functional recovery. Radiotherapy can 
lead to fatigue, skin reactions, nausea and diarrhea. It also shows 
changes in the connective tissue only after several years. That can 
lead to fibrosing of involved tissues and movement limitations. 
Chemotherapy and anti-hormonal therapies have many different 
side effects because they interfere with cell processes. Regarding 
the various chemotherapeutics these side effects are carefully 
described and can be found in the pharmacotherapeutic reference 
works. Many of the side effects described here include fatigue and 
a strong decrease in physical condition and muscle strength. 
Incidentally, also decrease of mental resilience and meaning in 
life.
And what role is there for the physical therapist
The physiotherapist knows from his expertise the importance of 
exercise and the need to pay attention to this. If the patient is 
unable to do this himself, or with any advice or general support, a 
referral to the physical therapist is appropriate. With these inter-
ventions, the physical therapist supports and promotes "the ability 
to adept" for the cancer patient. Maintaining or restoring physical 
condition and strength appear to be important in recent years not 
only after medical treatment, but also during treatment. With 
sufficient fitness, the applied chemotherapy can be better endured 
and the doctor does not have to reduce the optimal dosage due to 
unacceptable side effects. If there are physical movement restrict-
ions, treatment can be offered by the physical therapist. Experience 
figures in the Netherlands show that around 25% of patients 
require targeted specialist oncology-physiotherapy care, approx-
imately 5% requires specialist multidisciplinary rehabilitation 
care and that the majority can be guided with advice or general 
physiotherapy. This specialist physiotherapy is an expertise that 
has increased in recent years. In previous years, the physiotherap-
ist in some treatment centers was involved in the clinical care of 
these patients and also often in treating lymphatic problems after 
cancer treatment (see the article by colleague Mireille Lauret). 
With improving survival rates, cancer patients became more and 
more survivors, with more discomfort from all side effects that 
adversely affected their quality of life. Therefore, the call for this 
aftercare became ever greater. That is why the role of the physical 
therapist in supporting, improving and restoring physical possibili-
ties has grown and they fulfill an important task in care and after-
care. From patient to new person, with its own role in family, work 
and social society. A nuance is appropriate here, because by no 
means all cancer patients can be treated curatively. The 5-year 
survival rates have improved in recent decades from 25 to 65% 
over-all, for breast cancer even to 88%, unfortunately for lung 
cancer only to 19%.
Then why the specialty of Oncology Physiotherapy?
As described above, the role of the physiotherapist in cancer care 
has grown considerably in recent years. There is an increasing 
demand for expert treatment of patients suffering the effects of 
Sjúkraþjálfun Garðabæjar




this disease, the unwanted but unavoidable side effects of these 
often invasive treatments that leave their mark on all dimensions 
of human life. Being able to function physically in the greatest 
possible degree of independence is an important goal of every 
cancer patient. The limitations that arise can often be influenced 
by physiotherapy interventions. That is why it is important to 
know the background of the disease and its treatment options 
thoroughly. The first requirement for an oncology physiotherapist 
is knowledge! To have knowledge of the tumor types, their 
behaviors, the treatment options, the damage that this causes to 
the musculoskeletal system, the consequences of surgery, radio-
therapy, chemotherapy, immunotherapy and so on. Intersection of 
connective tissue structures, muscles and nerves leads to loss of 
function and limitations in independent functioning. And further 
changing tissue properties such as hardening of connective tissue 
as a result of radiotherapy, altered functioning of nerve pathways 
through chemotherapy, decreased heart function, a disturbed 
gastrointestinal system, insufficient lymph drainage, inexplicable 
fatigue. Just some known consequences, each with their own in-
fluence on being able to function safely, independently and effect-
ively. Secondly, it is important for an oncology physiotherapist to 
also know the non-physical changes. What are the consequences 
in daily life if these basic skills are no longer possible? If you are 
too tired to perform your daily activities, if you lack the strength 
and energy with every effort, if you are nauseated by chemo, the 
pillow is full of dropped hair, in short if you can no longer live 
your life the way you used to. How do relationships change during 
such a radical process, how do you hold on with so many life 
questions? Uncertainties and doubts that are very understandable 
and that can be demotivating and inhibiting in the physiothera-
peutic process of building strength and condition where possible, 
in the recovery of physical functioning both in the use of your 
limbs and in daily life. Quite a difficult competence for the 
oncology physiotherapist. As a third skill, knowing other forms of 
care and aftercare is important in order to be able to provide 
specific advice or referral to the patient in treatment requests 
outside the physiotherapeutic context. Multidisciplinary care is 
necessary here.
Finally, the oncology physiotherapist also fulfills the role of 
colleague consultant and advisor in questions from general 
physiotherapists who provide care to the large group of patients 
with single problems after or during cancer.
Oncology physiotherapy, how do you do that?
What options does the oncology physiotherapist have for perform-
ing these tasks and assignments? First of all the general compet-
ences of every physical therapist. In addition, a great deal of 
knowledge about cancer, the occurrence of various forms, the 
course to be expected, the chances of survival and the medical 
treatment options. Knowledge of all the consequences of these 
medical treatment options is also important to understand the 
consequences for physical functioning and to be able to intervene 
in it. In addition, knowledge and skills to guide patients in the 
other aspects of processing mentioned and experienced barriers to 
come to an active role in their own recovery. Patients benefit from 
their own active attitude to practice skills and mobility, to train in 
maintaining or improving physical condition and to work towards 
the best possible new situation in which control over their own 
lives can be regained as much as possible. In addition to support-
ing and treating cancer patients who are recovering from cancer 
disease and its treatment, there is still a large group of approxi-
mately 35% who cannot be treated curatively. They live with this 
disease for a short or longer period of time. They often have in-
creasingly symptoms of the disease and treatment. First in functi-
onal limitations, later in basic physical functions. This group of 
palliative patients require appropriate, sometimes period-wise 
treatment and counseling up to and including the terminal phase 
in which anxiety, pain and fatigue play an increasing and limiting 
role. A very important task has been set aside for the experienced 
physiotherapist. Oncology physiotherapy, how do we continue?
Within physiotherapy there is an increasing demand for expert 
care for cancer patients and survivors. In medical care, the contri-
bution of physiotherapy during and after primary treatment is 
more and more known, acknowledged and supported by scientific 
research. The contribution of the physiotherapist is highly appreci-
ated in palliative and terminal care. The dissemination of this role 
is greatly enhanced by the patients, who share their experiences 
with their doctors and family. Physiotherapists themselves 
improve the possibilities of care through targeted training and 
through the worldwide distribution of knowledge in this area.
At the Geneva congress 2019 of the World Confederation for 
Physiotherapy - WCPT – the board officially recognized the sub-
group "International Physiotherapists for HIV / AIDS, Oncology, 
Hospice and Palliative care", IPT-HOPE. This subgroup strives 
for worldwide dissemination of knowledge and skills of cancer 
related physiotherapy. On 14 and 15 May 2020, the second Inter-
national Conference on Physical Therapy in Oncology (ICPTO-
2020) will be organized at Copenhagen (Denmark) by the Dutch 
Institute of Allied Health Care (NPi), the Association of Danish 
Physiotherapists (DFys) and the Danish Society of Oncological 
and Palliative Physiotherapy (DOPF).
See: www.npi.nl/ ICPTO2020
Conclusion
The conclusion of the rise and growth of this new area within 
physiotherapy may therefore be: "Oncology physiotherapy is 
specialized physiotherapy for an exceptional target group in a 
special context.". In addition to the highly specialized medical 
care that primarily focuses on combating degenerated tissue, the 
malignant tumor, it is expert care from a holistic view of humanity, 
to get back to life! I hope you can develop this expertise in Iceland.
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